Abstract
O048 / #626
Topic: AS15 - Lupus Nephritis-Clinical
ABSTRACT CONCURRENT SESSION 08: RECENT ADVANCES IN LUPUS BIOMARKERS
23-05-2025 1:40 PM - 2:40 PM
Background/Purpose Lupus nephritis (LN) affects up to 50% of patients with lupus, of whom 40% will experience a subsequent renal flare, and up to 20% will progress to end-stage renal disease. Repeat kidney biopsies (KB) performed 2 years after the last LN flare have been shown to predict subsequent renal flares and renal dysfunction. In this study, we assessed whether 5 urinary biomarkers (UB), including CD163, MCP-1, Adiponectin, sVCAM-1 and PF4 measured 2 years after a LN flare, predict long-term renal outcomes.
Methods Patients who had a LN flare and stored urine 24±3 months after the LN flare were included in the study. The 5 UB levels were measured by ELISA 24±3 months after the LN flare. Examined renal outcomes: 1) Time to a subsequent LN flare (increase in proteinuria of at least 1000 mg/day if the baseline was <500 mg/day or doubling of proteinuria if the baseline was ≥500 mg/day, prompting a change in therapy) and 2) time to 30% decline in eGFR, after their 2-year urinary sample collection.
Results 69 patients with LN were included. The median (IQR) follow-up time after their 2-year urinary sample collection was 129 (97.5-150) months. 50 patients achieved proteinuria of ≤700 mg at 2 years after the LN flare. This subcohort of patients had significantly lower UB levels 2 years after the LN flare compared to patients who persisted with proteinuria >700 mg (Figure 1). In this subcohort of patients, 27 (54%) experienced a subsequent LN flare with a median time to flare (IQR) of 3.5 (1.67-6.87) years, and 10 (20%) had a 30% decline in eGFR at a median time of 4.38 (3.73-5.33) years after their 2-year urinary sample collection. Elevated levels of MCP-1 (HR 1.13 (1.01-1.27), p=0.03) and CD163 (HR 1.48 (1.15-1.90), p=0.002) predicted a subsequent LN flare. While CD163 (HR 1.31 (1.10-1.57), p=0.002), Adiponectin (HR 1.53 (1.22-1.91), p=0.0002), sVCAM-1 (HR 1.11 (1.03-1.21), p=0.006), and PF4 (HR 1.14 (1.04-1.25), p=0.003) predicted a 30% decline in eGFR (Table 1).
UB were significantly higher in patients who did not achieve an uPCR ≤700 mg (n=19) at 24±3 months after the LN flare as compared to those who did (n=50). Symbols represent the determination from a single individual, columns the median and the bars IQR.
Multivariable Cox Regression analysis. Predictors of adverse renal outcomes (Subcohort of patients who achieved a proteinuria of ≤700 mg at 24±3 months after the LN flare, N=50)
Conclusions UB measured 2 years after an LN flare predicted long-term renal outcomes.
- Copyright © 2025 by the Journal of Rheumatology
This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.
